BioDlink International Company Limited (BIODLINK-B) confirmed that shareholders overwhelmingly endorsed a new contract-development and manufacturing organisation (CDMO) master services agreement with WuXi XDC Cayman Inc. at the extraordinary general meeting held on 11 June 2026.

The single ordinary resolution—covering (1) ratification of the CDMO master services agreement dated 26 May 2026, (2) approval of annual transaction caps for the fiscal years ending 31 December 2026, 2027 and 2028, and (3) authorisation for directors to finalise related documents—garnered 140.92 million votes in favour, representing 99.90 % of the ballots cast. Only 0.10 % (0.14 million votes) were recorded against, ensuring smooth passage of the agreement.

Key voting parameters: • Shares in issue on the meeting date: 772.79 million. • Shares eligible to vote, after excluding 468.85 million shares held by WuXi XDC and its associates and 12.72 million award shares held in trust: 303.93 million. • Total votes cast: 141.06 million, equivalent to 46.39 % of the eligible shares.

With the resolution approved, BioDlink’s board is empowered to execute the CDMO agreement and implement the pre-set annual caps for 2026-2028, facilitating continued collaboration with WuXi XDC on contract development and manufacturing services.